上交所：对亚辉龙及时任董秘王鸣阳予以监管警示

Core Viewpoint - The Shanghai Stock Exchange issued a regulatory warning to Shenzhen Yahui Long Biotechnology Co., Ltd. for inaccurate and incomplete information disclosure regarding its strategic cooperation with Shenzhen Brain Machine Starlink Technology Co., Ltd. [1][2] Group 1: Company Actions - Shenzhen Yahui Long announced a strategic cooperation framework agreement with Brain Machine Starlink, focusing on product development, market promotion, and equity investment [1] - Following media attention, the company issued a supplementary announcement clarifying that Brain Machine Starlink's current research products only involve non-invasive technology and that some products are still in early development or preclinical stages [1][2] Group 2: Market Reaction - The announcement led to a 6.52% increase in the company's stock price, with trading volume rising by 299% compared to the previous trading day [2] Group 3: Regulatory Findings - The company was found to have inconsistent statements regarding the inclusion of invasive technology in its partnership, failing to adequately disclose risks related to cooperation feasibility and uncertainties [2] - The actions of the company violated multiple provisions of the Shanghai Stock Exchange's rules, leading to a regulatory warning for the company and its former board secretary, Wang Mingyang [2]